Dociparstat Sodium (CX-01)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dociparstat Sodium (CX-01), covering 2021-10-29 to 2021-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]